Fierce Biotech News & Reports
Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of …
Notable goes bankrupt, ending plans for Boehringer cancer drug
Oct 15, 2024 · Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for …
FDA approves Novocure’s tumor field therapy for metastatic NSCLC
Oct 16, 2024 · Novocure submitted Optune Lua for FDA review in NSCLC in December 2023, after also seeking a CE Mark approval in Europe. Around the same time—and following the …
Fierce Biotech Layoff Tracker 2024
March—18 companies. March 29 - Mustang Bio: Cell therapy-focused Mustang has laid off an undisclosed number of workers. The company declined to disclose how many employees …
Caris scores FDA approval for multi-cancer companion diagnostic …
Nov 13, 2024 · Caris Life Sciences has obtained an FDA approval for its MI Cancer Seek tumor profiling assay, unlocking its use as a companion diagnostic for multiple targeted medications …
Cour inks $940M-plus autoimmune deal with Roche's Genentech
Dec 3, 2024 · Chicago’s Cour Pharmaceuticals—recently honored as one of Fierce Biotech’s 2024 Fierce 15—is bringing its immunology mission to the fore with a new deal featuring Swiss …
A look at the R&D landscape in obesity, led by GLP-1s - Fierce …
Mar 19, 2024 · If you’re feeling like overnight obesity became the indication du jour, you’re not alone. Novo Nordisk was granted approval for semaglutide to be marketed as Wegovy for …
Novartis inks $150M deal for autoimmune molecular glue
Oct 28, 2024 · Don’t stop Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after signing a deal with Novartis to the tune of $150 million for a molecular glue degrader, …
After a tough year, Exscientia folds into Recursion - Fierce Biotech
Aug 8, 2024 · But, in 2022, Bayer parted ways on a 240 million euro ($243 million) partnership. And, despite adding a collaboration with Merck KGaA in September 2023 that could top $1 …
FDA approves Exact Sciences’ next-gen Cologuard Plus home test
Oct 4, 2024 · Ten years after first collecting an FDA approval, it’s time for version number two. Exact Sciences has received an agency green light for Cologuard Plus, the next generation of …